论文部分内容阅读
本文测定了肝硬化、肝肾综合征(HRS)患者及健康对照者尿液中 TXA_2代谢稳定产物血栓素 B_2(TXB_2) 和 PGI_2代谢稳定性产物6-酮-前列腺素 F_(Ia)(6-keto-PGF_(Ia))的含量,以观察其与肝硬化及肝肾综合征(HRS)的关系。
In this study, TXB_2, a metabolite of TXA 2 and a metabolite of 6-keto-PGF 1α (6-keto-prostaglandin F (Ia)), which is a metabolite of PGI 2 in urine of patients with cirrhosis and hepatorenal syndrome keto-PGF_ (Ia)), to observe its relationship with cirrhosis and hepatorenal syndrome (HRS).